scholarly journals Treatment of asymptomatic carotid artery disease: Similar early outcomes after carotid stenting for high-risk patients and endarterectomy for standard-risk patients

2006 ◽  
Vol 43 (5) ◽  
pp. 953-958 ◽  
Author(s):  
Leopoldo A. Marine ◽  
Brian G. Rubin ◽  
Rishindra Reddy ◽  
Luis A. Sanchez ◽  
Juan C. Parodi ◽  
...  
Keyword(s):  
High Risk ◽  
Carotid Artery ◽  
Carotid Artery Disease ◽  
Carotid Stenting ◽  
Asymptomatic Carotid ◽  
High Risk Patients ◽  
Risk Patients ◽  
Artery Disease ◽  
Standard Risk

Angioplasty and stenting for carotid artery stenosis: indications, techniques, results, and complications

1998 ◽  
Vol 5 (6) ◽  
pp. E5 ◽  
Author(s):  
Giuseppe Lanzino ◽  
Richard D. Fessler ◽  
Robert A. Mericle ◽  
Ajay K. Wakhloo ◽  
Lee R. Guterman ◽  
...  
Keyword(s):  
High Risk ◽  
Carotid Artery ◽  
Carotid Artery Stenosis ◽  
Carotid Artery Disease ◽  
Artery Stenosis ◽  
High Risk Patients ◽  
Clinical Series ◽  
Risk Patients ◽  
Artery Disease ◽  
Angioplasty And Stenting

Following the favorable results obtained in the treatment of coronary artery disease, combined angioplasty and stenting has been advocated for the treatment of carotid artery stenosis as well. Although widespread application of angioplasty and stenting for carotid artery disease is neither indicated nor recommended, it may be a viable alternative therapy for select patients who are high-risk patients for surgery. The results of early series have suggested that endoluminal revascularization in these high-risk patients can be performed with an acceptable degree of safety. Although the incidence of death and major stroke rates following angioplasty and stenting procedures compares favorably with surgery, results of more recent clinical series have suggested that the incidence of perioperative transient neurological events and minor strokes may be higher than suggested by earlier reports, especially in patients with recent neurological symptoms and “unstable” plaques. In this article, the authors review the current potential indications for and preliminary results of angioplasty and stenting and describe their procedural technique. In addition, potential applications of stenting to intracranial thromboocclusive carotid artery disease are reviewed.

scholarly journals Protected Carotid Stenting in High-Risk Patients With Severe Carotid Artery Stenosis

2006 ◽  
Vol 47 (12) ◽  
pp. 2384-2389 ◽  
Author(s):  
Robert D. Safian ◽  
John F. Bresnahan ◽  
Michael R. Jaff ◽  
Malcolm Foster ◽  
J. Michael Bacharach ◽  
...  
Keyword(s):  
High Risk ◽  
Carotid Artery ◽  
Carotid Artery Stenosis ◽  
Carotid Stenting ◽  
Artery Stenosis ◽  
High Risk Patients ◽  
Risk Patients

Cerebral protection devices for use during carotid artery angioplasty with stenting: A health technology assessment

2006 ◽  
Vol 22 (1) ◽  
pp. 119-129 ◽  
Author(s):  
Devidas Menon ◽  
Tania Stafinski
Keyword(s):  
High Risk ◽  
Carotid Artery ◽  
Carotid Artery Disease ◽  
Cerebral Protection ◽  
Success Rates ◽  
Economic Implications ◽  
High Risk Patients ◽  
Significant Difference ◽  
Risk Patients ◽  
Protection Devices

Objectives:This study sought to examine the safety, efficacy, and economic implications of the use of cerebral protection devices during carotid artery angioplasty and stenting (CAS) in high-risk patients with severe carotid artery disease (CAD).Methods:A comprehensive search for peer- and non–peer-reviewed studies that compared carotid endarterectomy (CEA) or CAS without cerebral protection to CAS with cerebral protection and appeared in the English language literature between January 1990 and January 2005 was completed. Information from studies identified was extracted using a common data abstraction form and then critically appraised against published quality assessment criteria.Results:Of the eight studies found, six provided information on technical or procedural success rates, with values ranging from 95.6 percent to 100 percent. Three of the four studies comparing groups of patients who received CAS with cerebral protection with those who received only CAS reported a non-statistically significantly higher 30-day incidence of death and stroke (major or minor) in the latter group. None of the three studies comparing CAS with cerebral protection to CEA demonstrated a statistically significant difference in the 30-day incidence of death, major stroke, or myocardial infarction between treatment groups. No economic analyses were found.Conclusions:In high-risk patients with severe CAD, the evidence suggests that CAS with cerebral protection may offer a safe and efficacious alternative to CEA, reducing the risk of embolic peri-procedural complications associated with CAS to acceptable levels.

Sign in / Sign up

Export Citation Format

Share Document